Nexsen Secures Medical-Device Quality Certification, Advancing StrepSure Toward Market
NXN: $0.160 +0.00% · MC: $32M
Nexsen Limited (ASX: NXN) has secured ISO 13485 certification covering StrepSure’s design, development and manufacture, establishing a certified quality system intended to support regulatory submissions and commercial supply. The certification advances the product toward an Asia-Pacific launch and FDA submission, and the company says the quality framework can also support other diagnostics in its pipeline. Nexsen also appointed Amanda Burgess as company secretary and changed its registered office.

Comments